Academic Journal
Q1Nature Immunology
About Nature Immunology
Nature Immunology is a scholarly journal published by Nature Research. SCImago 2025 places it in Q1 with an SJR of 11.131 and an H-index of 468.
Its listed coverage is 2000-2026 and its research categories include Immunology (Q1); Immunology and Allergy (Q1). The 2025 dataset reports 314 documents and 11141 citations across the latest three-year reporting window.
Nature Immunology is a prestigious scientific journal that plays a critical role in advancing the field of immunology. Published by Nature Publishing Group, this journal is renowned for its comprehensive coverage of the latest research in immunology, immune system functions, and related therapeutic strategies. It is one of the most highly regarded journals in the immunology community, attracting top-tier scientists, researchers, and clinicians from around the world.
What Makes Nature Immunology Stand Out?
Nature Immunology distinguishes itself through its focus on high-quality, cutting-edge research. It is widely respected for publishing articles that span a broad spectrum of immunology, ranging from basic immunological mechanisms to translational studies and clinical applications. The journal aims to bridge the gap between fundamental science and therapeutic innovation, making it a crucial resource for immunologists, biologists, and healthcare professionals.
The journal’s editorial standards ensure that only the most impactful studies are featured. Each article is rigorously reviewed by experts in the field, ensuring that the research is robust, well-supported, and relevant to current scientific and medical challenges. Nature Immunology is particularly recognized for its deep dives into cellular and molecular immunology, infectious disease immunity, autoimmune disorders, cancer immunology, and immunotherapy.
Key Areas of Focus
-
Immune System Function: Nature Immunology publishes groundbreaking research on how the immune system works, from its basic components like T cells, B cells, and macrophages to complex processes like antigen presentation, cytokine signaling, and immune memory. This area of research is vital for understanding how the body defends itself against pathogens and maintains homeostasis.
-
Immunotherapy and Disease Treatment: With the increasing importance of immunotherapy in cancer treatment, autoimmune disease management, and other therapeutic fields, Nature Immunology is a key platform for exploring novel immunotherapeutic strategies. The journal features studies on checkpoint inhibitors, CAR-T cell therapies, monoclonal antibodies, and other promising treatment options.
-
Infectious Disease Immunology: The journal provides in-depth research on the immune system’s response to infectious diseases caused by bacteria, viruses, fungi, and parasites. Studies in this category are critical for developing vaccines, therapeutic antibodies, and novel treatments to combat emerging infectious diseases.
-
Autoimmunity and Chronic Inflammation: Nature Immunology also publishes essential research on autoimmune diseases like rheumatoid arthritis, lupus, and multiple sclerosis, focusing on the mechanisms that drive chronic inflammation and immune system dysregulation. This research helps to unravel the underlying causes of autoimmune diseases and identifies potential therapeutic targets.
Impact on Immunology Research and Medicine
As one of the leading journals in immunology, Nature Immunology has had a profound impact on both basic research and clinical medicine. The insights and breakthroughs published in the journal often shape the direction of future immunological research and inform clinical practices. Researchers and clinicians rely on its findings to improve diagnostic tools, enhance therapeutic approaches, and develop new vaccines and treatments that can potentially save lives.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Nature Immunology is one of the leading scientific journals dedicated to publishing cutting-edge research in the field of immunology. As the immune system plays a crucial role in protecting the body against infections, diseases, and other harmful agents, understanding its complex mechanisms is vital. This journal explores the molecular, cellular, and genetic underpinnings of immune responses, offering comprehensive insights that advance both basic science and clinical applications.
Key Areas Covered in Nature Immunology
-
Basic Immunology: Nature Immunology delves deeply into the basic principles of immunology, including the structure and function of immune cells, signaling pathways, and the role of the immune system in maintaining homeostasis. Topics like antigen presentation, T and B cell development, and cytokine signaling are explored extensively, making it an essential resource for researchers and students alike.
-
Immunogenetics: Genetic factors play a critical role in the immune system’s functioning. Nature Immunology covers the latest studies on immunogenetics, including how variations in immune-related genes can affect susceptibility to diseases, autoimmune conditions, and responses to infections. The journal regularly features articles that explain the genetics of immune cell differentiation and function.
-
Innate and Adaptive Immunity: The journal provides detailed insights into both innate and adaptive immunity. It highlights the interactions between innate immune cells (like macrophages and dendritic cells) and adaptive immune responses (involving T and B cells). Understanding these processes is key to developing therapies for immune-related diseases, such as cancer, allergies, and autoimmune disorders.
-
Immunotherapies and Vaccine Development: Nature Immunology is a pivotal source for the latest breakthroughs in immunotherapy and vaccine development. From monoclonal antibodies to CAR T-cell therapies, the journal covers innovative treatments aimed at harnessing the immune system to combat diseases. Additionally, it provides in-depth analyses of vaccine design, including those for infectious diseases and cancer immunotherapy.
-
Immunology of Diseases: One of the most important aspects of immunology is its role in various diseases. Nature Immunology publishes research on the immune system’s involvement in both infectious diseases (like HIV, tuberculosis, and malaria) and non-infectious diseases (such as cancer, diabetes, and autoimmune disorders). These studies contribute to the development of targeted immunotherapies and novel treatment options.
-
Inflammation and Immune Regulation: The regulation of inflammation is a critical area of study in immunology. Nature Immunology explores how immune cells manage inflammation, ensuring that it is activated when necessary to fight infections but also resolved promptly to prevent chronic conditions. Chronic inflammation is often linked to diseases like cardiovascular disorders and cancer, making this an essential topic for research.
Nature Immunology’s Contribution to Global Health
Nature Immunology not only contributes to advancing scientific knowledge but also plays a significant role in improving global health. By providing a platform for high-impact research on immune-related diseases, the journal facilitates the development of better diagnostic tools, therapies, and vaccines. The journal’s focus on immunotherapy has been especially instrumental in the fight against cancer, with many groundbreaking studies paving the way for new treatment options.
Recent Research Articles
Latest publications matched automatically by ISSN.
Intratumoral T cell activation kills tumors regardless of T cell specificity
Olivia C. Ghirardelli Smith, Tyler T. Dao, Noah V. Gavil, Stephen D. O’Flanagan et al.
2026-09-08 · DOI: 10.1038/s41590-026-02642-zID2 orchestrates the final ‘E-scape’ from the −165-kb Zeb2 enhancer for cDC1 specification
Jingjing Yan, Yugu Zhang, Michaël Chopin
2026-09-08 · DOI: 10.1038/s41590-026-02659-4The dual roles of uterine monocytes in regulation of tissue homeostasis throughout reproductive cycles in health and disease
Abdullah Shahzad, Olivia Moran, Yousef Alebrahim, Stefano Colombo et al.
2026-09-08 · DOI: 10.1038/s41590-026-02651-yNeutrophil-hybrid CAR-macrophages bring double trouble to tumors
Marie Siwicki, Paul Kubes
2026-09-08 · DOI: 10.1038/s41590-026-02650-zNew frontiers in pathogen immunity
Mauro Gaya, Mads Gyrd-Hansen, Anna Kajaste-Rudnitski, Matteo Iannacone et al.
2026-09-08 · DOI: 10.1038/s41590-026-02657-6Innate immune imprints shape HIV-1 reservoir cell persistence during long-term antiretroviral therapy
Toong Seng Tan, WeiWei Sun, Ce Gao, Mathias Viard et al.
2026-09-01 · DOI: 10.1038/s41590-026-02637-wNatural killers blast HIV reservoir landscape
Daniel A. Armendariz, Valter Silva Monteiro, Ya-Chi Ho
2026-09-01 · DOI: 10.1038/s41590-026-02635-yAuthor Correction: Peyer’s patch M cells organize an epithelial niche that sustains group 3 innate lymphoid cells and IL-22
Wang H. J. Cao, Yue You, Nancy Wang, M. Zeeshan Chaudhry et al.
2026-09-01 · DOI: 10.1038/s41590-026-02669-2Immune-mediated rheumatoid arthritis: from single-cell genomics to new therapies
Lionel B. Ivashkiv
2026-08-31 · DOI: 10.1038/s41590-026-02639-8Monocyte-derived galectin-1hi cells provide innate immune help in the generation of functional memory CD8+ T cells
Kihong Lim, Ankit Dahal, Xiurui Lv, Kyun-Do Kim et al.
2026-08-31 · DOI: 10.1038/s41590-026-02638-9Good neighbors make lasting memory
Mohammad Heidarian, Vladimir P. Badovinac
2026-08-31 · DOI: 10.1038/s41590-026-02645-wAuthor Correction: Short IL-18 generated by caspase-3 cleavage mobilizes NK cells to suppress tumor growth
Junchen Shen, Yu Zhang, Wenbo Tang, Mingxia Yang et al.
2026-08-26 · DOI: 10.1038/s41590-026-02662-9Aging by impaired efferocytosis
Stephanie Houston
2026-09 · DOI: 10.1038/s41590-026-02647-8Rear entry pyroptosis inhibition
Nicholas J. Bernard
2026-09 · DOI: 10.1038/s41590-026-02646-9Breg cells to the rescue
Laurie A. Dempsey
2026-09 · DOI: 10.1038/s41590-026-02648-7Microglia effects
Ioana Staicu
2026-09 · DOI: 10.1038/s41590-026-02649-6ID2 secures cDC1 specification by antagonizing E proteins at a pleiotropic Zeb2 enhancer
Feiya Ou, Tian-Tian Liu, Siling Du, Jing Chen et al.
2026-08-25 · DOI: 10.1038/s41590-026-02632-1Collaborative functionality between three types of inflammation in idiopathic pulmonary fibrosis
Thomas Fabre, Thomas A. Wynn, Kevin M. Hart
2026-09 · DOI: 10.1038/s41590-026-02616-1Progenitor T cells drive chronic pulmonary type 2 inflammation
Radomir Kratchmarov, Xiaojiong Jia, Jun Nagai, Gaspar A. Pacheco et al.
2026-09 · DOI: 10.1038/s41590-026-02619-yRegulatory CD8+ T lymphocytes control intestinal inflammation
Holm H. Uhlig
2026-09 · DOI: 10.1038/s41590-026-02627-yReviews
Community Reviews
Version History
April 14, 2025 at 11:55 am
March 21, 2025